General Information
Version
1.1
Revision date
2023-05-11
Product name
THINNER 35
Substance name
THINNER 35
CAS No.
78-93-3
REACH No
01-2119457290-43
1.2.1 Relevant identified uses
Professional use
supplier name
CRC Industries Europe B.V
Emergency telephone
+32(0)52/45.60.11, +32 70 245 245
Icons in SDS
Company Information
company name
CRC Industries Europe B.V
e-mail address of the competent person responsible for the Safety Data Sheet
hse@crcind.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319, H336
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May cause drowsiness or dizziness. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapour. H319 - Causes serious eye irritation. H336 - May cause drowsiness or dizziness.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 - Keep container tightly closed. P271 - Use only outdoors or in a well-ventilated area. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P405 - Store locked up. P501 - Dispose of contents/container to a hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH066 - Repeated exposure may cause skin dryness or cracking.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII
Further information
The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
